Endothelial cells in dengue hemorrhagic fever

Antiviral Research

Volumn 109, Issue 1, 2014, Pages 160-170

  Srikiatkhachorn, Anon ^a   Kelley, James F ^b,c  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

^c UNIVERSITY OF HAWAII   (United States)

Author keywords

Dengue hemorrhagic fever; Dengue virus; Endothelial barrier integrity; Endothelial cells; Vascular leak

Indexed keywords

ALBUMIN; COMPLEMENT COMPONENT C1S; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C4B; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HEPARIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; NONSTRUCTURAL PROTEIN 1; NONSTRUCTURAL PROTEIN 4B; NONSTRUCTURAL PROTEIN 5; RANTES; TRANSFERRIN; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VIRUS ANTIGEN; VIRUS PROTEIN; ANTIVIRUS AGENT;

AUTOIMMUNITY; BLOOD CLOTTING DISORDER; CAPILLARY PERMEABILITY; CELL ACTIVATION; COMPLEMENT ACTIVATION; CYTOKINE RELEASE; DENDRITIC CELL; DENGUE; DENGUE VIRUS; DIAPEDESIS; DISEASE MODEL; DISEASE SEVERITY; EDEMA; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; EXTRACELLULAR FLUID; GENETIC TRANSCRIPTION; HUMAN; INNATE IMMUNITY; LYMPHOCYTE; MACROPHAGE; MEDIATOR RELEASE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; REVIEW; SHOCK; URINARY EXCRETION; VASCULAR ENDOTHELIUM; VASCULAR LEAKAGE; VIRUS VIRULENCE; ANIMAL; DRUG EFFECTS; IMMUNOLOGY; PHYSIOLOGY; SEVERE DENGUE; VIROLOGY;

ANIMALS; ANTIVIRAL AGENTS; DENGUE VIRUS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; SEVERE DENGUE;

EID: 84905189360     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2014.07.005     Document Type: Review

References (154)

1. W.C. Aird Phenotypic heterogeneity of the endothelium. I. Structure, function, and mechanisms Circ. Res. 100 2007 158 173 (Pubitemid 46208717)
2. C. Ajariyakhajorn, M.P. Mammen Jr., T.P. Endy, M. Gettayacamin, A. Nisalak, S. Nimmannitya, and D.H. Libraty Randomized, placebo-controlled trial of nonpegylated and pegylated forms of recombinant human alpha interferon 2a for suppression of dengue virus viremia in rhesus monkeys Antimicrob. Agents Chemother. 49 2005 4508 4514 (Pubitemid 41552579)
3. R. Akkina Human immune responses and potential for vaccine assessment in humanized mice Curr. Opin. Immunol. 3 2013 403 409
4. N. Alexander, A. Balmaseda, I.C. Coelho, E. Dimaano, T.T. Hien, N.T. Hung, T. Janisch, A. Kroeger, L.C. Lum, E. Martinez, J.B. Siqueira, T.T. Thuy, I. Villalobos, E. Villegas, and B. Wills Multicentre prospective study on dengue classification in four South-east Asian and three Latin American countries Trop. Med. Int. Health. 8 2011 936 948
5. J. An, D.S. Zhou, J.L. Zhang, H. Morida, J.L. Wang, and K. Yasui Dengue-specific CD8+ T cells have both protective and pathogenic roles in dengue virus infection Immunol. Lett. 95 2004 167 174 (Pubitemid 39237662)
6. M.T. Arevalo, P.J. Simpson-Haidaris, Z. Kou, J.J. Schlesinger, and X. Jin Primary human endothelial cells support direct but not antibody-dependent enhancement of dengue viral infection J. Med. Virol. 81 2009 519 528
7. A. Atrasheuskaya, P. Petzelbauer, T.M. Fredeking, and G. Ignatyev Anti-TNF antibody treatment reduces mortality in experimental dengue virus infection FEMS Immunol. Med. Microbiol. 35 2003 33 42 (Pubitemid 36173502)
8. P. Avirutnan, A. Fuchs, R.E. Hauhart, P. Somnuke, S. Youn, M.S. Diamond, and J.P. Atkinson Antagonism of the complement component C4 by flavivirus nonstructural protein NS1 J. Exp. Med. 207 2010 793 806
9. P. Avirutnan, P. Malasit, B. Seliger, S. Bhakdi, and M. Husmann Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis J. Immunol. 161 1998 6338 6346 (Pubitemid 28536010)
10. P. Avirutnan, N. Punyadee, S. Noisakran, C. Komoltri, S. Thiemmeca, K. Auethavornanan, A. Jairungsri, R. Kanlaya, N. Tangthawornchaikul, C. Puttikhunt, S.N. Pattanakitsakul, P.T. Yenchitsomanus, J. Mongkolsapaya, W. Kasinrerk, N. Sittisombut, M. Husmann, M. Blettner, S. Vasanawathana, S. Bhakdi, and P. Malasit Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement J. Infect. Dis. 193 2006 1078 1088
11. P. Avirutnan, L. Zhang, N. Punyadee, A. Manuyakorn, C. Puttikhunt, W. Kasinrerk, P. Malasit, J.P. Atkinson, and M.S. Diamond Secreted NS1 of dengue virus attaches to the surface of cells via interactions with heparan sulfate and chondroitin sulfate E PLoS Pathog. 3 2007 e183
12. E.L. Azeredo, L.M. De Oliveira-Pinto, S.M. Zagne, D.I. Cerqueira, R.M. Nogueira, and C.F. Kubelka NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease Clin. Exp. Immunol. 143 2006 345 356
13. A. Azizan, K. Fitzpatrick, A. Signorovitz, R. Tanner, H. Hernandez, L. Stark, and M. Sweat Profile of time-dependent VEGF upregulation in human pulmonary endothelial cells, HPMEC-ST1.6R infected with DENV-1, -2, -3, and -4 viruses Virol. J. 6 2009 49
14. A. Azizan, J. Sweat, C. Espino, J. Gemmer, L. Stark, and D. Kazanis Differential proinflammatory and angiogenesis-specific cytokine production in human pulmonary endothelial cells, HPMEC-ST1.6R infected with dengue-2 and dengue-3 virus J. Virol. Methods 138 2006 211 217 (Pubitemid 44633458)
15. S.J. Balsitis, J. Coloma, G. Castro, A. Alava, D. Flores, J.H. McKerrow, P.R. Beatty, and E. Harris Tropism of dengue virus in mice and humans defined by viral nonstructural protein 3-specific immunostaining Am. J. Trop. Med. Hyg. 80 2009 416 424
16. S. Bandyopadhyay, L.C. Lum, and A. Kroeger Classifying dengue: a review of the difficulties in using the WHO case classification for dengue haemorrhagic fever Trop. Med. Int. Health 11 2006 1238 1255 (Pubitemid 44125713)
17. D.F. Barreto, C.M. Takiya, H.G. Schatzmayr, R.M. Nogueira, C. Farias-Filho Jda, and O.M. Barth Histopathological and ultrastructural aspects of mice lungs experimentally infected with dengue virus serotype 2 Mem. Inst. Oswaldo Cruz 102 2007 175 182 (Pubitemid 46535879)
18. O.M. Barth, D.F. Barreto, M.V. Paes, C.M. Takiya, A.T. Pinhao, and H.G. Schatzmayr Morphological studies in a model for dengue-2 virus infection in mice Mem. Inst. Oswaldo Cruz 101 2006 905 915 (Pubitemid 46129493)
19. C.A. Basilio-de-Oliveira, G.R. Aguiar, M.S. Baldanza, O.M. Barth, W.A. Eyer-Silva, and M.V. Paes Pathologic study of a fatal case of dengue-3 virus infection in Rio de Janeiro, Brazil Braz. J. Infect. Dis. 9 2005 341 347 (Pubitemid 43141340)
20. A. Basu, P. Jain, P. Sarkar, S. Gangodkar, D. Deshpande, K. Ganti, S. Shetty, and K. Ghosh Dengue virus infection of SK Hep1 cells: inhibition of in vitro angiogenesis and altered cytomorphology by expressed viral envelope glycoprotein FEMS Immunol. Med. Microbiol. 62 2011 140 147
21. Bauer, K., Weitz, J., 1994. Laboratory markers of coagulation and fibrinolysis. Homeostasis and Thrombosis: Basic Principles and Clinical Practice, third ed. Lippincott, Philadelphia, pp. 1197-1210.
22. D.B. Bethell, J. Gamble, P.L. Pham, M.D. Nguyen, T.H. Tran, T.H. Ha, T.N. Tran, T.H. Dong, I.B. Gartside, N.J. White, and N.P. Day Noninvasive measurement of microvascular leakage in patients with dengue hemorrhagic fever Clin. Infect. Dis. 32 2001 243 253 (Pubitemid 32524794)
23. N. Bhamarapravati Hemostatic defects in dengue hemorrhagic fever Rev. Infect. Dis. 11 Suppl. 4 1989 S826 S829
24. N. Bhamarapravati, P. Tuchinda, and V. Boonyapaknavik Pathology of Thailand haemorrhagic fever: a study of 100 autopsy cases Ann. Trop. Med. Parasitol. 61 1967 500 510
25. J.E. Blaney Jr., N.S. Sathe, L. Goddard, C.T. Hanson, T.A. Romero, K.A. Hanley, B.R. Murphy, and S.S. Whitehead Dengue virus type 3 vaccine candidates generated by introduction of deletions in the 3′ untranslated region (3′-UTR) or by exchange of the DENV-3 3′-UTR with that of DENV-4 Vaccine 26 2008 817 828
26. V.A. Bokisch, H.J. Muller-Eberhard, and F.J. Dixon The role of complement in hemorrhagic shock syndrome (dengue) Trans. Assoc. Am. Phys. 86 1973 102 110
27. S.M. Bonner, and M.A. O'Sullivan Endothelial cell monolayers as a model system to investigate dengue shock syndrome J. Virol. Methods 71 1998 159 167 (Pubitemid 28196170)
28. B.W. Boom, M. Mommaas, M.R. Daha, and B.J. Vermeer Complement-mediated endothelial cell damage in immune complex vasculitis of the skin: ultrastructural localization of the membrane attack complex J. Invest. Dermatol. 93 1989 68S 72S
29. S. Boonpucknavig, V. Boonpucknavig, N. Bhamarapravati, and S. Nimmannitya Immunofluorescence study of skin rash in patients with dengue hemorrhagic fever Arch. Pathol. Lab. Med. 103 1979 463 466 (Pubitemid 9251125)
30. E.L. Braga, P. Moura, L.M. Pinto, S.R. Ignacio, M.J. Oliveira, M.T. Cordeiro, and C.F. Kubelka Detection of circulant tumor necrosis factor-alpha, soluble tumor necrosis factor p75 and interferon-gamma in Brazilian patients with dengue fever and dengue hemorrhagic fever Mem. Inst. Oswaldo Cruz 96 2001 229 232 (Pubitemid 33640932)
31. M. Bray, R. Men, and C.J. Lai Monkeys immunized with intertypic chimeric dengue viruses are protected against wild-type virus challenge J. Virol. 70 1996 4162 4166 (Pubitemid 26157401)
32. M.G. Brown, L.L. Hermann, A.C. Issekutz, J.S. Marshall, D. Rowter, A. Al-Afif, and R. Anderson Dengue virus infection of mast cells triggers endothelial cell activation J. Virol. 85 2011 1145 1150
33. A. Bunyaratvej, P. Butthep, S. Yoksan, and N. Bhamarapravati Dengue viruses induce cell proliferation and morphological changes of endothelial cells Southeast Asian J. Trop. Med. Public Health 28 Suppl. 3 1997 32 37
34. P. Butthep, S. Chunhakan, K. Tangnararatchakit, S. Yoksan, K. Pattanapanyasat, and A. Chuansumrit Elevated soluble thrombomodulin in the febrile stage related to patients at risk for dengue shock syndrome Pediatr. Infect. Dis. J. 25 2006 894 897 (Pubitemid 44510582)
35. C.C. Carlos, K. Oishi, M.T. Cinco, C.A. Mapua, S. Inoue, D.J. Cruz, M.A. Pancho, C.Z. Tanig, R.R. Matias, K. Morita, F.F. Natividad, A. Igarashi, and T. Nagatake Comparison of clinical features and hematologic abnormalities between dengue fever and dengue hemorrhagic fever among children in the Philippines Am. J. Trop. Med. Hyg. 73 2005 435 440 (Pubitemid 41278725)
36. J.M. Carr, H. Hocking, K. Bunting, P.J. Wright, A. Davidson, J. Gamble, C.J. Burrell, and P. Li Supernatants from dengue virus type-2 infected macrophages induce permeability changes in endothelial cell monolayers J. Med. Virol. 69 2003 521 528 (Pubitemid 36249866)
37. H.C. Chen, F.M. Hofman, J.T. Kung, Y.D. Lin, and B.A. Wu-Hsieh Both virus and tumor necrosis factor alpha are critical for endothelium damage in a mouse model of dengue virus-induced hemorrhage J. Virol. 81 2007 5518 5526 (Pubitemid 46846992)
38. S.T. Chen, Y.L. Lin, M.T. Huang, M.F. Wu, S.C. Cheng, H.Y. Lei, C.K. Lee, T.W. Chiou, C.H. Wong, and S.L. Hsieh CLEC5A is critical for dengue-virus-induced lethal disease Nature 453 2008 672 676
39. R.C. Christofferson, M.K. McCracken, A.M. Johnson, D.M. Chisenhall, and C.N. Mores Development of a transmission model for dengue virus Virol. J. 10 2013 127
40. Y.C. Chuang, H.Y. Lei, Y.S. Lin, H.S. Liu, H.L. Wu, and T.M. Yeh Dengue virus-induced autoantibodies bind to plasminogen and enhance its activation J. Immunol. 187 2011 6483 6490
41. A. Chuansumrit, S. Wangruangsatid, Y. Lektrakul, M.N. Chua, M.R. Zeta Capeding, and O.M. Bech Control of bleeding in children with dengue hemorrhagic fever using recombinant activated factor VII: a randomized, double-blind, placebo-controlled study Blood Coagul. Fibrinolysis 16 2005 549 555 (Pubitemid 41658973)
42. J.A. Colbert, A. Gordon, R. Roxelin, S. Silva, J. Silva, C. Rocha, and E. Harris Ultrasound measurement of gallbladder wall thickening as a diagnostic test and prognostic indicator for severe dengue in pediatric patients Pediatr. Infect. Dis. J. 26 2007 850 852 (Pubitemid 47329862)
43. A. Couvelard, P. Marianneau, C. Bedel, M.T. Drouet, F. Vachon, D. Henin, and V. Deubel Report of a fatal case of dengue infection with hepatitis: demonstration of dengue antigens in hepatocytes and liver apoptosis Hum. Pathol. 30 1999 1106 1110 (Pubitemid 29427169)
44. N. Dalrymple, and E.R. Mackow Productive dengue virus infection of human endothelial cells is directed by heparan sulfate-containing proteoglycan receptors J. Virol. 85 2011 9478 9485
45. N.A. Dalrymple, and E.R. Mackow Endothelial cells elicit immune-enhancing responses to dengue virus infection J. Virol. 86 2012 6408 6415
46. J.L. Deen, E. Harris, B. Wills, A. Balmaseda, S.N. Hammond, C. Rocha, N.M. Dung, N.T. Hung, T.T. Hien, and J.J. Farrar The WHO dengue classification and case definitions: time for a reassessment Lancet 368 2006 170 173 (Pubitemid 43994174)
47. E. Dejana, E. Tournier-Lasserve, and B.M. Weinstein The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications Dev. Cell 16 2009 209 221
48. B.E. Dewi, T. Takasaki, and I. Kurane In vitro assessment of human endothelial cell permeability: effects of inflammatory cytokines and dengue virus infection J. Virol. Methods 121 2004 171 180 (Pubitemid 39295707)
49. B.E. Dewi, T. Takasaki, and I. Kurane Peripheral blood mononuclear cells increase the permeability of dengue virus-infected endothelial cells in association with downregulation of vascular endothelial cadherin J. Gen. Virol. 89 2008 642 652
50. E.M. Dimaano, M. Saito, S. Honda, E.A. Miranda, M.T. Alonzo, M.D. Valerio, C.A. Mapua, S. Inoue, A. Kumaori, R. Matias, F.F. Natividad, and K. Oishi Lack of efficacy of high-dose intravenous immunoglobulin treatment of severe thrombocytopenia in patients with secondary dengue virus infection Am. J. Trop. Med. Hyg. 77 2007 1135 1138 (Pubitemid 351837807)
51. K. Djamiatun, A.J. van der Ven, P.G. de Groot, S.M. Faradz, D. Hapsari, W.M. Dolmans, S. Sebastian, R. Fijnheer, and Q. de Mast Severe dengue is associated with consumption of von Willebrand factor and its cleaving enzyme ADAMTS-13 PLoS Negl. Trop. Dis. 6 2012 e1628
52. H.F. Dvorak Vascular permeability to plasma, plasma proteins, and cells: an update Curr. Opin. Hematol. 17 2010 225 229
53. A.K. Falconar The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis Arch. Virol. 142 1997 897 916 (Pubitemid 27218413)
54. N. Ferrara, K.J. Hillan, and W. Novotny Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy Biochem. Biophys. Res. Commun. 333 2005 328 335 (Pubitemid 40848295)
55. M.S. Freire, R.S. Marchevsky, L.F. Almeida, A.M. Yamamura, E.C. Caride, P.A. Brindeiro, M.C. Motta, R.M. Nogueira, C.F. Kubelka, M.C. Bonaldo, and R. Galler Wild dengue virus types 1, 2 and 3 viremia in rhesus monkeys Mem. Inst. Oswaldo Cruz 102 2007 203 208 (Pubitemid 46535883)
56. J.W. Fresh, V. Reyes, E.J. Clarke, and C.V. Uylangco Philippine hemorrhagic fever: a clinical, laboratory, and necropsy study J. Lab. Clin. Med. 73 1969 451 458
57. G. Garcia, N. Gonzalez, A.B. Perez, B. Sierra, E. Aguirre, D. Rizo, A. Izquierdo, L. Sanchez, D. Diaz, M. Lezcay, B. Pacheco, K. Hirayama, and M.G. Guzman Long-term persistence of clinical symptoms in dengue-infected persons and its association with immunological disorders Int. J. Infect. Dis. 15 2011 e38 e43
58. M.S. Gordon, K. Margolin, M. Talpaz, G.W. Sledge Jr., E. Holmgren, R. Benjamin, S. Stalter, S. Shak, and D. Adelman Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer J. Clin. Oncol. 19 2001 843 850 (Pubitemid 32119100)
59. M. Groger, W. Pasteiner, G. Ignatyev, U. Matt, S. Knapp, A. Atrasheuskaya, E. Bukin, P. Friedl, D. Zinkl, R. Hofer-Warbinek, K. Zacharowski, P. Petzelbauer, and S. Reingruber Peptide Bbeta(15-42) preserves endothelial barrier function in shock PLoS ONE 4 2009 e5391
60. R. Guabiraba, A.G. Besnard, R.E. Marques, I. Maillet, C.T. Fagundes, T.M. Conceicao, N.M. Rust, S. Charreau, I. Paris, J.C. Lecron, J.C. Renauld, V. Quesniaux, A.T. Da Poian, L.B. Arruda, D.G. Souza, B. Ryffel, and M.M. Teixeira IL-22 modulates IL-17A production and controls inflammation and tissue damage in experimental dengue infection Eur. J. Immunol. 43 6 2013 1529 1544
61. D.J. Gubler Dengue and dengue hemorrhagic fever: its history and resurgence as a global public health problem D.J. Gubler, G. Kuno, Dengue and Dengue Hemorrhagic Fever 1997 UK CAB International, Wallingford 1 22
62. Gubler, D., Kuno, G., Markoff, L., 2007. Flavivirus. Field's Virology, fifth ed. Lippincott Williams & Wilkins, Philadelphia.
63. F. Guirakhoo, J. Arroyo, K.V. Pugachev, C. Miller, Z.X. Zhang, R. Weltzin, K. Georgakopoulos, J. Catalan, S. Ocran, K. Soike, M. Ratterree, and T.P. Monath Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine J. Virol. 75 2001 7290 7304 (Pubitemid 32737987)
64. Y.H. Huang, H.Y. Lei, H.S. Liu, Y.S. Lin, S.H. Chen, C.C. Liu, and T.M. Yeh Tissue plasminogen activator induced by dengue virus infection of human endothelial cells J. Med. Virol. 70 2003 610 616
65. Y.H. Huang, H.Y. Lei, H.S. Liu, Y.S. Lin, C.C. Liu, and T.M. Yeh Dengue virus infects human endothelial cells and induces IL-6 and IL-8 production Am. J. Trop. Med. Hyg. 63 2000 71 75
66. A. Huerta-Zepeda, C. Cabello-Gutierrez, J. Cime-Castillo, V. Monroy-Martinez, M.E. Manjarrez-Zavala, M. Gutierrez-Rodriguez, R. Izaguirre, and B.H. Ruiz-Ordaz Crosstalk between coagulation and inflammation during dengue virus infection Thromb. Haemost. 99 2008 936 943 (Pubitemid 351705312)
67. K. Jessie, M.Y. Fong, S. Devi, S.K. Lam, and K.T. Wong Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization J. Infect. Dis. 189 2004 1411 1418 (Pubitemid 38543590)
68. Z. Jiang, X. Tang, R. Xiao, L. Jiang, and X. Chen Dengue virus regulates the expression of hemostasis-related molecules in human vein endothelial cells J. Infect. 55 2007 e23 e28
69. R. Kanlaya, S.N. Pattanakitsakul, S. Sinchaikul, S.T. Chen, and V. Thongboonkerd Alterations in actin cytoskeletal assembly and junctional protein complexes in human endothelial cells induced by dengue virus infection and mimicry of leukocyte transendothelial migration J. Proteome Res. 8 2009 2551 2562
70. J.F. Kelley, P.H. Kaufusi, and V.R. Nerurkar Dengue hemorrhagic fever-associated immunomediators induced via maturation of dengue virus nonstructural 4B protein in monocytes modulate endothelial cell adhesion molecules and human microvascular endothelial cells permeability Virology 422 2012 326 337
71. A. Khongphatthanayothin, P. Phumaphuti, K. Thongchaiprasit, and Y. Poovorawan Serum levels of sICAM-1 and sE-selectin in patients with dengue virus infection Jpn. J. Infect. Dis. 59 2006 186 188 (Pubitemid 43959978)
72. P. Koraka, B. Murgue, X. Deparis, E.C. Van Gorp, T.E. Setiati, A.D. Osterhaus, and J. Groen Elevation of soluble VCAM-1 plasma levels in children with acute dengue virus infection of varying severity J. Med. Virol. 72 2004 445 450 (Pubitemid 38133985)
73. E. Kraiselburd, D.J. Gubler, and M.J. Kessler Quantity of dengue virus required to infect rhesus monkeys Trans. R. Soc. Trop. Med. Hyg. 79 1985 248 251
74. E. Kraiselburd, M.J. Kessler, and G. Torres-Blasini Lack of viraemia and limited antibody response of dengue virus immune rhesus monkeys after vaccination with DEN-2/S-1 vaccine Trans. R. Soc. Trop. Med. Hyg. 78 1984 445 448
75. S.A. Kularatne, C. Walathara, S.I. Mahindawansa, S. Wijesinghe, M.M. Pathirage, P.V. Kumarasiri, and A.M. Dissanayake Efficacy of low dose dexamethasone in severe thrombocytopenia caused by dengue fever: a placebo controlled study Postgrad. Med. J. 85 2009 525 529
76. P. Kumpers, F. Gueler, S. David, P.V. Slyke, D.J. Dumont, J.K. Park, C.L. Bockmeyer, S.M. Parikh, H. Pavenstadt, H. Haller, and N. Shushakova The synthetic tie2 agonist peptide vasculotide protects against vascular leakage and reduces mortality in murine abdominal sepsis Crit. Care 15 2011 R261
77. J.G. Kuruvilla, R.M. Troyer, S. Devi, and R. Akkina Dengue virus infection and immune response in humanized RAG2(-/-)gamma(c)(-/-) (RAG-hu) mice Virology 369 2007 143 152 (Pubitemid 350029864)
78. Leitmeyer, K.C., Vaughn, D.W., Watts, D.M., Salas, R., Villalobos, I., de Chacon, Ramos, C., Rico-Hesse, R., 1999. Dengue virus structural differences that correlate with pathogenesis. J. Virol. 73, 4738-4747. (Pubitemid 29246733)
79. H. Liao, J. Xu, and J. Huang FasL/Fas pathway is involved in dengue virus induced apoptosis of the vascular endothelial cells J. Med. Virol. 82 2010 1392 1399
80. D.H. Libraty, T.P. Endy, H.S. Houng, S. Green, S. Kalayanarooj, S. Suntayakorn, W. Chansiriwongs, D.W. Vaughn, A. Nisalak, F.A. Ennis, and A.L. Rothman Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections J. Infect. Dis. 185 2002 1213 1221 (Pubitemid 34439127)
81. D.H. Libraty, T.P. Endy, S. Kalayanarooj, W. Chansiriwongs, A. Nisalak, S. Green, F.A. Ennis, and A.L. Rothman Assessment of body fluid compartment volumes by multifrequency bioelectrical impedance spectroscopy in children with dengue Trans. R. Soc. Trop. Med. Hyg. 96 2002 295 299 (Pubitemid 34785069)
82. D.H. Libraty, P.R. Young, D. Pickering, T.P. Endy, S. Kalayanarooj, S. Green, D.W. Vaughn, A. Nisalak, F.A. Ennis, and A.L. Rothman High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever J. Infect. Dis. 186 2002 1165 1168 (Pubitemid 35177121)
83. A.Y. Limon-Flores, M. Perez-Tapia, I. Estrada-Garcia, G. Vaughan, A. Escobar-Gutierrez, J. Calderon-Amador, S.E. Herrera-Rodriguez, A. Brizuela-Garcia, M. Heras-Chavarria, A. Flores-Langarica, L. Cedillo-Barron, and L. Flores-Romo Dengue virus inoculation to human skin explants: an effective approach to assess in situ the early infection and the effects on cutaneous dendritic cells Int. J. Exp. Pathol. 86 2005 323 334 (Pubitemid 41413627)
84. D. Limonta, V. Capo, G. Torres, A.B. Perez, and M.G. Guzman Apoptosis in tissues from fatal dengue shock syndrome J. Clin. Virol. 40 2007 50 54 (Pubitemid 47302858)
85. C.F. Lin, H.Y. Lei, A.L. Shiau, C.C. Liu, H.S. Liu, T.M. Yeh, S.H. Chen, and Y.S. Lin Antibodies from dengue patient sera cross-react with endothelial cells and induce damage J. Med. Virol. 69 2003 82 90
86. C.F. Lin, H.Y. Lei, A.L. Shiau, H.S. Liu, T.M. Yeh, S.H. Chen, C.C. Liu, S.C. Chiu, and Y.S. Lin Endothelial cell apoptosis induced by antibodies against dengue virus nonstructural protein 1 via production of nitric oxide J. Immunol. 169 2002 657 664
87. C.F. Lin, S.W. Wan, M.C. Chen, S.C. Lin, C.C. Cheng, S.C. Chiu, Y.L. Hsiao, H.Y. Lei, H.S. Liu, T.M. Yeh, and Y.S. Lin Liver injury caused by antibodies against dengue virus nonstructural protein 1 in a murine model Lab. Invest. 88 2008 1079 1089
88. Lin, Y.S., Yeh, T.M., Lin, C.F., Wan, S.W., Chuang, Y.C., Hsu, T.K., Liu, H.S., Liu, C.C., Anderson, R., Lei, H.Y., 2011. Molecular mimicry between virus and host and its implications for dengue disease pathogenesis. Exp. Biol. Med. 236, 515-523.
89. Lindenbach, B.D., Thiel, H.-J., Rice, C.M., 2007. Flaviviridae: the viruses and their replication. Field's Virology. Lippincott Williams & Wilkins, Philadelphia.
90. I.J. Liu, C.Y. Chiu, Y.C. Chen, and H.C. Wu Molecular mimicry of human endothelial cell antigen by autoantibodies to nonstructural protein 1 of dengue virus J. Biol. Chem. 286 2011 9726 9736
91. P. Liu, M. Woda, F.A. Ennis, and D.H. Libraty Dengue virus infection differentially regulates endothelial barrier function over time through type I interferon effects J. Infect. Dis. 200 2009 191 201
92. P.Y. Lozach, L. Burleigh, I. Staropoli, E. Navarro-Sanchez, J. Harriague, J.L. Virelizier, F.A. Rey, P. Despres, F. Arenzana-Seisdedos, and A. Amara Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals J. Biol. Chem. 280 2005 23698 23708 (Pubitemid 40884852)
93. N. Luplertlop, D. Misse, D. Bray, V. Deleuze, J.P. Gonzalez, V. Leardkamolkarn, H. Yssel, and F. Veas Dengue-virus-infected dendritic cells trigger vascular leakage through metalloproteinase overproduction EMBO Rep. 7 2006 1176 1181 (Pubitemid 44660576)
94. P. Malasit Complement and dengue haemorrhagic fever/shock syndrome Southeast Asian J. Trop. Med. Public Health 18 1987 316 320
95. F.J. Malinoski, S.E. Hasty, M.A. Ussery, and J.M. Dalrymple Prophylactic ribavirin treatment of dengue type 1 infection in rhesus monkeys Antiviral. Res. 13 1990 139 149
96. J. Martin, L. Hermida, J. Castro, L. Lazo, R. Martinez, L. Gil, Y. Romero, P. Puente, S. Zaragoza, K. Cosme, M.G. Guzman, J. Cardosa, and G. Guillen Viremia and antibody response in green monkeys (Chlorocebus aethiops sabaeus) infected with dengue virus type 2: a potential model for vaccine testing Microbiol. Immunol. 53 2009 216 223
97. C.L. Medin, K.A. Fitzgerald, and A.L. Rothman Dengue virus nonstructural protein NS5 induces interleukin-8 transcription and secretion J. Virol. 79 2005 11053 11061 (Pubitemid 41170646)
98. M. Michels, A.J. van der Ven, K. Djamiatun, R. Fijnheer, P.G. de Groot, A.W. Griffioen, S. Sebastian, S.M. Faradz, and Q. de Mast Imbalance of angiopoietin-1 and angiopoetin-2 in severe dengue and relationship with thrombocytopenia, endothelial activation, and vascular stability Am. J. Trop. Med. Hyg. 87 2012 943 946
99. E.A. Miller, and J.D. Ernst Anti-TNF immunotherapy and tuberculosis reactivation: another mechanism revealed J. Clin. Invest. 119 2009 1079 1082
100. Min, M., U, Tu, Aye, M., Shwe, T.N., Swe, T., 1975. Hydrocortisone in the management of dengue shock syndrome. Southeast Asian J. Trop. Med. Public Health 6, 573-579.
101. Y. Modis, S. Ogata, D. Clements, and S.C. Harrison Structure of the dengue virus envelope protein after membrane fusion Nature 427 2004 313 319 (Pubitemid 38133652)
102. J. Mota, and R. Rico-Hesse Humanized mice show clinical signs of dengue fever according to infecting virus genotype J. Virol. 83 2009 8638 8645
103. J. Mota, and R. Rico-Hesse Dengue virus tropism in humanized mice recapitulates human dengue fever PLoS ONE 6 2011 e20762
104. S. Mukhopadhyay, R.J. Kuhn, and M.G. Rossmann A structural perspective of the flavivirus life cycle Nat. Rev. 3 2005 13 22 (Pubitemid 40028466)
105. S. Nimmannitya Clinical manifestations of dengue/dengue haemorrhagic fever P. Thongcharoen, Monograph on Dengue/Dengue Haemorrhagic Fever 1993 World Health Organization New Delhi 48 57
106. M.V. Paes, H.L. Lenzi, A.C. Nogueira, G.J. Nuovo, A.T. Pinhao, E.M. Mota, C.A. Basilio-de-Oliveira, H. Schatzmayr, O.M. Barth, and A.M. Alves Hepatic damage associated with dengue-2 virus replication in liver cells of BALB/c mice Lab. Invest. 89 2009 1140 1151
107. M.V. Paes, A.T. Pinhao, D.F. Barreto, S.M. Costa, M.P. Oliveira, A.C. Nogueira, C.M. Takiya, J.C. Farias-Filho, H.G. Schatzmayr, A.M. Alves, and O.M. Barth Liver injury and viremia in mice infected with dengue-2 virus Virology 338 2005 236 246 (Pubitemid 41024860)
108. Panpanich, R., Sornchai, P., Kanjanaratanakorn, K., 2006. Corticosteroids for treating dengue shock syndrome. Cochrane Database Syst. Rev. 3, CD003488.
109. S.T. Perry, M.D. Buck, E.M. Plummer, R.A. Penmasta, H. Batra, E.J. Stavale, K.L. Warfield, R.A. Dwek, T.D. Butters, D.S. Alonzi, S.M. Lada, K. King, B. Klose, U. Ramstedt, and S. Shresta An iminosugar with potent inhibition of dengue virus infection in vivo Antiviral Res. 98 2013 35 43
110. C.N. Peyrefitte, B. Pastorino, G.E. Grau, J. Lou, H. Tolou, and P. Couissinier-Paris Dengue virus infection of human microvascular endothelial cells from different vascular beds promotes both common and specific functional changes J. Med. Virol. 78 2006 229 242 (Pubitemid 43132568)
111. H.S. Pramuljo, and S.R. Harun Ultrasound findings in dengue haemorrhagic fever Pediatr. Radiol. 21 1991 100 102
112. T.R. Prestwood, D.M. Prigozhin, K.L. Sharar, R.M. Zellweger, and S. Shresta A mouse-passaged dengue virus strain with reduced affinity for heparan sulfate causes severe disease in mice by establishing increased systemic viral loads J. Virol. 82 2008 8411 8421
113. R. Putnak, J. Fuller, L. VanderZanden, B.L. Innis, and D.W. Vaughn Vaccination of rhesus macaques against dengue-2 virus with a plasmid DNA vaccine encoding the viral pre-membrane and envelope genes Am. J. Trop. Med. Hyg. 68 2003 469 476 (Pubitemid 38230650)
114. K. Raviprakash, D. Wang, D. Ewing, D.H. Holman, K. Block, J. Woraratanadharm, L. Chen, C. Hayes, J.Y. Dong, and K. Porter A tetravalent dengue vaccine based on a complex adenovirus vector provides significant protection in rhesus monkeys against all four serotypes of dengue virus J. Virol. 82 2008 6927 6934 (Pubitemid 351977713)
115. M.P. Ruiz-Torres, G. Perez-Rivero, M. Rodriguez-Puyol, D. Rodriguez-Puyol, and M.L. Diez-Marques The leukocyte-endothelial cell interactions are modulated by extracellular matrix proteins Cell. Physiol. Biochem. 17 2006 221 232 (Pubitemid 43946278)
116. Sabin, A.B., Schlesinger, R.W., 1945. Production of immunity to dengue with virus modified by propagation in mice. Science 101, 640-642.
117. D.M. Salgado, J.M. Eltit, K. Mansfield, C. Panqueba, D. Castro, M.R. Vega, K. Xhaja, D. Schmidt, K.J. Martin, P.D. Allen, J.A. Rodriguez, J.H. Dinsmore, J.R. Lopez, and I. Bosch Heart and skeletal muscle are targets of dengue virus infection Pediatr. Infect. Dis. J. 29 2010 238 242
118. W. Schul, W. Liu, H.Y. Xu, M. Flamand, and S.G. Vasudevan A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs J. Infect. Dis. 195 2007 665 674
119. R.M. Scott, A. Nisalak, K.H. Eckels, M. Tingpalapong, V.R. Harrison, D.J. Gould, F.E. Chapple, and P.K. Russell Dengue-2 vaccine: viremia and immune responses in rhesus monkeys Infect. Immun. 27 1980 181 186 (Pubitemid 10211954)
120. R.C. Seet, A.W. Chow, A.M. Quek, Y.H. Chan, and E.C. Lim Relationship between circulating vascular endothelial growth factor and its soluble receptors in adults with dengue virus infection: a case-control study Int. J. Infect. Dis. 13 2009 e248 e253
121. S. Shresta, K.L. Sharar, D.M. Prigozhin, P.R. Beatty, and E. Harris Murine model for dengue virus-induced lethal disease with increased vascular permeability J. Virol. 80 2006 10208 10217 (Pubitemid 44522614)
122. M. Simmons, T. Burgess, J. Lynch, and R. Putnak Protection against dengue virus by non-replicating and live attenuated vaccines used together in a prime boost vaccination strategy Virology 396 2010 280 288
123. D. Sosothikul, P. Seksarn, S. Pongsewalak, U. Thisyakorn, and J. Lusher Activation of endothelial cells, coagulation and fibrinolysis in children with dengue virus infection Thromb. Haemost. 97 2007 627 634 (Pubitemid 46592941)
124. A. Srikiatkhachorn, C. Ajariyakhajorn, T.P. Endy, S. Kalayanarooj, D.H. Libraty, S. Green, F.A. Ennis, and A.L. Rothman Virus-induced decline in soluble vascular endothelial growth receptor 2 is associated with plasma leakage in dengue hemorrhagic fever J. Virol. 81 2007 1592 1600 (Pubitemid 46214434)
125. Srikiatkhachorn, A., Krautrachue, A., Ratanaprakarn, W., Wongtapradit, L., Nithipanya, N., Kalayanarooj, S., Nisalak, A., Thomas, S.J., Gibbons, R.V., Mammen, Jr., M.P., Libraty, D.H., Ennis, F.A., Rothman, A.L., Green, S., 2007. Natural history of plasma leakage in dengue hemorrhagic fever: a serial ultrasonographic study. Pediatr. Infect. Dis. J. 26, 283-290 (discussion 291-282). (Pubitemid 46596649)
126. D.A. Stein, S.T. Perry, M.D. Buck, C.S. Oehmen, M.A. Fischer, E. Poore, J.L. Smith, A.M. Lancaster, A.J. Hirsch, M.K. Slifka, J.A. Nelson, S. Shresta, and K. Fruh Inhibition of dengue virus infections in cell cultures and in AG129 mice by a small interfering RNA targeting a highly conserved sequence J. Virol. 85 2011 10154 10166
127. Sumarmo, Talogo, W., Asrin, A., Isnuhandojo, B., Sahudi, A., 1982. Failure of hydrocortisone to affect outcome in dengue shock syndrome. Pediatrics 69, 45-49. (Pubitemid 12209667)
128. D.S. Sun, C.C. King, H.S. Huang, Y.L. Shih, C.C. Lee, W.J. Tsai, C.C. Yu, and H.H. Chang Antiplatelet autoantibodies elicited by dengue virus non-structural protein 1 cause thrombocytopenia and mortality in mice J. Thromb. Haemost. 5 2007 2291 2299
129. W. Sun, A. Nisalak, M. Gettayacamin, K.H. Eckels, J.R. Putnak, D.W. Vaughn, B.L. Innis, S.J. Thomas, and T.P. Endy Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination J. Infect. Dis. 193 2006 1658 1665 (Pubitemid 43839470)
130. G.K. Tan, J.K. Ng, A.H. Lim, K.P. Yeo, V. Angeli, and S. Alonso Subcutaneous infection with non-mouse adapted dengue virus D2Y98P strain induces systemic vascular leakage in AG129 mice Ann. Acad. Med. Singapore 40 2011 523 532
131. G.K. Tan, J.K. Ng, S.L. Trasti, W. Schul, G. Yip, and S. Alonso A non mouse-adapted dengue virus strain as a new model of severe dengue infection in AG129 mice PLoS Negl. Trop. Dis. 4 2010 e672
132. B. Tassaneetrithep, T.H. Burgess, A. Granelli-Piperno, C. Trumpfheller, J. Finke, W. Sun, M.A. Eller, K. Pattanapanyasat, S. Sarasombath, D.L. Birx, R.M. Steinman, S. Schlesinger, and M.A. Marovich DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells J. Exp. Med. 197 2003 823 829 (Pubitemid 36437860)
133. S. Tassniyom, S. Vasanawathana, A. Chirawatkul, and S. Rojanasuphot Failure of high-dose methylprednisolone in established dengue shock syndrome: a placebo-controlled, double-blind study Pediatrics 92 1993 111 115 (Pubitemid 23188877)
134. S. Tassniyom, S. Vasanawathana, T. Dhiensiri, A. Nisalak, and A. Chirawatkul Failure of carbazochrome sodium sulfonate (AC-17) to prevent dengue vascular permeability or shock: a randomized, controlled trial J. Pediatr. 131 1997 525 528 (Pubitemid 28006922)
135. J.R. Teijaro, K.B. Walsh, S. Cahalan, D.M. Fremgen, E. Roberts, F. Scott, E. Martinborough, R. Peach, M.B. Oldstone, and H. Rosen Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection Cell 146 2011 980 991
136. C.S. Tseng, H.W. Lo, H.C. Teng, W.C. Lo, and C.G. Ker Elevated levels of plasma VEGF in patients with dengue hemorrhagic fever FEMS Immunol. Med. Microbiol. 43 2005 99 102
137. F.F. Vasanwala, T.L. Thein, Y.S. Leo, V.C. Gan, Y. Hao, L.K. Lee, and D.C. Lye Predictive value of proteinuria in adult dengue severity PLoS Negl. Trop. Dis. 8 2014 e2712
138. D.W. Vaughn, S. Green, S. Kalayanarooj, B.L. Innis, S. Nimmannitya, S. Suntayakorn, T.P. Endy, B. Raengsakulrach, A.L. Rothman, F.A. Ennis, and A. Nisalak Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity J. Infect. Dis. 181 2000 2 9 (Pubitemid 30049026)
139. P.M. Venkata Sai, B. Dev, and R. Krishnan Role of ultrasound in dengue fever Br. J. Radiol. 78 2005 416 418 (Pubitemid 40691744)
140. R.V. Warke, K. Xhaja, K.J. Martin, M.F. Fournier, S.K. Shaw, N. Brizuela, N. de Bosch, D. Lapointe, F.A. Ennis, A.L. Rothman, and I. Bosch Dengue virus induces novel changes in gene expression of human umbilical vein endothelial cells J. Virol. 77 2003 11822 11832 (Pubitemid 37271679)
141. H.J. Weiss, and S.B. Halstead Studies of hemostasis in Thai hemorrhagic fever J. Pediatr. 66 1965 918 926
142. World Health Organization Dengue Hemorrhagic Fever: Diagnosis, Treatment, Prevention and Control 2nd ed. 1997 World health Organization Geneva
143. World Health Organization, 2009. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control. New Edition, Geneva.
144. B.A. Wills, E.E. Oragui, N.M. Dung, H.T. Loan, N.V. Chau, J.J. Farrar, and M. Levin Size and charge characteristics of the protein leak in dengue shock syndrome J. Infect. Dis. 190 2004 810 818 (Pubitemid 39050012)
145. B.A. Wills, E.E. Oragui, A.C. Stephens, O.A. Daramola, N.M. Dung, H.T. Loan, N.V. Chau, M. Chambers, K. Stepniewska, J.J. Farrar, and M. Levin Coagulation abnormalities in dengue hemorrhagic fever: serial investigations in 167 Vietnamese children with dengue shock syndrome Clin. Infect. Dis. 35 2002 277 285 (Pubitemid 34800275)
146. B.A. Wu-Hsieh, Y.T. Yen, and H.C. Chen Dengue hemorrhage in a mouse model Ann. N.Y. Acad. Sci. 1171 Suppl. 1 2009 E42 E47
147. S.J. Wu, G. Grouard-Vogel, W. Sun, J.R. Mascola, E. Brachtel, R. Putvatana, M.K. Louder, L. Filgueira, M.A. Marovich, H.K. Wong, A. Blauvelt, G.S. Murphy, M.L. Robb, B.L. Innes, D.L. Birx, C.G. Hayes, and S.S. Frankel Human skin Langerhans cells are targets of dengue virus infection Nat. Med. 6 2000 816 820 (Pubitemid 30469433)
148. J.C. Yang, L. Haworth, R.M. Sherry, P. Hwu, D.J. Schwartzentruber, S.L. Topalian, S.M. Steinberg, H.X. Chen, and S.A. Rosenberg A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer N. Engl. J. Med. 349 2003 427 434 (Pubitemid 36910021)
149. T.M. Yeh, S.H. Liu, K.C. Lin, C. Kuo, S.Y. Kuo, T.Y. Huang, Y.R. Yen, R.K. Wen, L.C. Chen, and T.F. Fu Dengue virus enhances thrombomodulin and ICAM-1 expression through the macrophage migration inhibitory factor induction of the MAPK and PI3K signaling pathways PLoS ONE 8 2013 e55018
150. Y.T. Yen, H.C. Chen, Y.D. Lin, C.C. Shieh, and B.A. Wu-Hsieh Enhancement by tumor necrosis factor alpha of dengue virus-induced endothelial cell production of reactive nitrogen and oxygen species is key to hemorrhage development J. Virol. 82 2008 12312 12324
151. S.R. Zaki, P.W. Greer, L.M. Coffield, C.S. Goldsmith, K.B. Nolte, K. Foucar, R.M. Feddersen, R.E. Zumwalt, G.L. Miller, and A.S. Khan et al. Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease Am. J. Pathol. 146 1995 552 579
152. C.A. Zampieri, N.J. Sullivan, and G.J. Nabel Immunopathology of highly virulent pathogens: insights from Ebola virus Nat. Immunol. 8 2007 1159 1164 (Pubitemid 350011751)
153. C. Zehetner, R. Kirchmair, S. Huber, M.T. Kralinger, and G.F. Kieselbach Plasma levels of vascular endothelial growth factor before and after intravitreal injection of bevacizumab, ranibizumab and pegaptanib in patients with age-related macular degeneration, and in patients with diabetic macular oedema Br. J. Ophthalmol. 97 2013 454 459
154. R.M. Zellweger, T.R. Prestwood, and S. Shresta Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease Cell Host Microbe 7 2010 128 139